{
    "organizations": [],
    "uuid": "7fe1f23a71f559b8a011ce2d238e93e3c477f816",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bayer-fda-report-reaffirms-safety/brief-bayer-fda-report-reaffirms-safety-profile-and-effectiveness-of-xarelto-in-routine-clinical-practice-idUSFWN1PB13T",
    "ord_in_thread": 0,
    "title": "BRIEF-Bayer: FDA Report Reaffirms Safety Profile And Effectiveness Of Xarelto In Routine Clinical Practice",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - BAYER AG:\n* FDA REPORT REAFFIRMS SAFETY PROFILE AND EFFECTIVENESS OF BAYER'S XARELTO IN ROUTINE CLINICAL PRACTICE Source text: bit.ly/2DDuMIB Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-16T21:34:00.000+02:00",
    "crawled": "2018-01-17T20:14:39.021+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "bayer",
        "ag",
        "fda",
        "report",
        "reaffirms",
        "safety",
        "profile",
        "effectiveness",
        "bayer",
        "xarelto",
        "routine",
        "clinical",
        "practice",
        "source",
        "text",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}